Ananthasayanam Jasvant Ram, Saravanan Jaypradha, Gunasekaran Dhivya, Meganathan Samaran, Natarajan Paarthipan
Radiodiagnosis, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus. 2024 Sep 13;16(9):e69377. doi: 10.7759/cureus.69377. eCollection 2024 Sep.
Lung masses pose a significant diagnostic challenge due to their diverse causes, from benign hamartomas to malignant bronchogenic carcinoma. Multi-detector CT (MDCT) is essential in evaluating these masses, offering detailed morphological insights to help differentiate between benign and malignant lesions. However, a definitive diagnosis often requires histopathological confirmation. CT-guided biopsy is crucial, providing a minimally invasive method to obtain tissue samples and thus guiding clinical management and treatment decisions.
The primary objective of this study was to assess the diagnostic accuracy of MDCT in differentiating between benign and malignant lung mass lesions. The study focused on evaluating the characteristic features of lung masses on MDCT that aid in this differentiation, correlating imaging findings with histopathological results from CT-guided biopsies, and determining the overall diagnostic utility of MDCT in thoracic lesions.
This hospital-based observational study was conducted over a period of 17 months. The study included 52 patients with thoracic lesions, identified through imaging techniques such as chest radiographs and CT scans. These patients underwent CT-guided biopsy, with tissue samples sent for histopathological examination. Inclusion criteria involved patients with clinically and radiographically diagnosed lung masses, while exclusion criteria included those who did not consent, had contraindications to contrast media, or had conditions such as severe respiratory distress or coagulopathy. The data were analyzed using descriptive statistics, with efficacy measures such as yield and failure rates of CT-guided biopsies and validation measures like sensitivity, specificity, positive predictive value, and negative predictive value for MDCT.
The study included 52 patients (50% male, 50% female), aged 16-80, with the most common age group being 51-60 years. Lesions were mainly in the lung parenchyma (65.38%), followed by the mediastinum (15.38%), hilar region (11.54%), and pleura (7.69%). MDCT evaluation classified 84.44% of the lesions as malignant, characterized by irregular contours, inhomogeneous texture, and contrast enhancement, while 15.55% were benign. Histopathology confirmed 42 malignant lesions, with squamous cell carcinoma being the most prevalent. Benign lesions included abscesses, tuberculosis, and pneumonitis. The study achieved a 100% success rate for CT-guided biopsy, with one minor complication (pneumothorax). The diagnostic accuracy of MDCT was notable, with a sensitivity of 100% for detecting malignancies, a specificity of 77.78%, a positive predictive value of 87.50%, and a negative predictive value of 100%, emphasizing its effectiveness in thoracic lesion evaluation.
MDCT is a highly effective tool in the evaluation of lung masses, providing critical information that aids in distinguishing between benign and malignant lesions. When combined with CT-guided biopsy, it offers a reliable method for obtaining diagnostic tissue samples, with a high degree of accuracy and a low complication rate. The study underscores the importance of integrating imaging and histopathological findings in the management of thoracic lesions, ultimately enhancing diagnostic precision and informing appropriate clinical interventions.
肺部肿块因其病因多样,从良性错构瘤到恶性支气管癌,给诊断带来了重大挑战。多排螺旋CT(MDCT)在评估这些肿块时至关重要,它能提供详细的形态学见解,有助于区分良性和恶性病变。然而,明确诊断通常需要组织病理学证实。CT引导下活检至关重要,它提供了一种微创方法来获取组织样本,从而指导临床管理和治疗决策。
本研究的主要目的是评估MDCT在区分良性和恶性肺部肿块病变方面的诊断准确性。该研究重点评估MDCT上有助于这种区分的肺部肿块特征,将影像学表现与CT引导下活检的组织病理学结果相关联,并确定MDCT在胸部病变中的整体诊断效用。
这项基于医院的观察性研究持续了17个月。该研究纳入了52例胸部病变患者,这些患者通过胸部X线片和CT扫描等影像学技术确诊。这些患者接受了CT引导下活检,并将组织样本送去进行组织病理学检查。纳入标准包括临床和影像学诊断为肺部肿块的患者,排除标准包括不同意者、对造影剂有禁忌证者或有严重呼吸窘迫或凝血功能障碍等情况的患者。数据采用描述性统计进行分析,包括CT引导下活检的成功率和失败率等效能指标,以及MDCT的敏感性、特异性、阳性预测值和阴性预测值等验证指标。
该研究纳入了52例患者(男性占50%,女性占50%),年龄在16 - 80岁之间,最常见的年龄组为51 - 60岁。病变主要位于肺实质(65.38%),其次是纵隔(15.38%)、肺门区域(11.54%)和胸膜(7.69%)。MDCT评估将84.44%的病变分类为恶性,其特征为轮廓不规则、质地不均匀和有对比增强,而15.55%为良性。组织病理学证实了42例恶性病变,其中鳞状细胞癌最为常见。良性病变包括脓肿、肺结核和肺炎。CT引导下活检的成功率为100%,出现了1例轻微并发症(气胸)。MDCT的诊断准确性显著,检测恶性肿瘤的敏感性为100%,特异性为77.78%,阳性预测值为87.50%,阴性预测值为100%,强调了其在胸部病变评估中的有效性。
MDCT是评估肺部肿块的高效工具,提供了有助于区分良性和恶性病变的关键信息。当与CT引导下活检相结合时,它提供了一种获取诊断组织样本的可靠方法,具有高度准确性和低并发症发生率。该研究强调了在胸部病变管理中整合影像学和组织病理学结果的重要性,最终提高诊断精度并为适当的临床干预提供依据。